| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035959006 |
| P356 | DOI | 10.1007/S40475-014-0019-6 |
| P932 | PMC publication ID | 4126259 |
| P698 | PubMed publication ID | 25110633 |
| P5875 | ResearchGate publication ID | 262876296 |
| P50 | author | Mussaret Bano Zaidi | Q42769621 |
| P2093 | author name string | Teresa Estrada-García | |
| P2860 | cites work | Trend and disease burden of bacillary dysentery in China (1991-2000) | Q24647991 |
| Global, regional, and national causes of child mortality in 2008: a systematic analysis | Q28282386 | ||
| A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology | Q28767862 | ||
| Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis | Q33350981 | ||
| Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh | Q33369800 | ||
| Haemolytic uraemic syndrome during shigellosis | Q33401184 | ||
| Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease | Q33403923 | ||
| Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes | Q33478268 | ||
| Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. | Q33500466 | ||
| A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation | Q33518017 | ||
| Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides | Q33557728 | ||
| Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 | ||
| Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri | Q33627338 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. | Q34301619 | ||
| Bacterial invasion: the paradigms of enteroinvasive pathogens | Q34312229 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. | Q34487453 | ||
| Causative species and serotypes of shigellosis in mainland China: systematic review and meta-analysis | Q34534027 | ||
| Shigella dysenteriae serotype 1, Kolkata, India | Q34560061 | ||
| Prevalence and antimicrobial susceptibility patterns of Shigella species in Asmara, Eritrea, northeast Africa. | Q34572104 | ||
| Serodiversity and antimicrobial resistance pattern of Shigella isolates at Gondar University teaching hospital, Northwest Ethiopia | Q34605678 | ||
| Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic | Q34731265 | ||
| Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India | Q35548340 | ||
| Decreasing Shigellosis-related Deaths withoutShigellaspp.–specific Interventions, Asia | Q35804868 | ||
| Broadly protective Shigella vaccine based on type III secretion apparatus proteins | Q35805439 | ||
| Childhood shigellosis at King Chulalongkorn Memorial Hospital, Bangkok, Thailand: a 5-year review (1996-2000). | Q36241531 | ||
| The lipopolysaccharide of Shigella bacteria as a virulence factor | Q36654698 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis | Q37056339 | ||
| Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study | Q37061211 | ||
| Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. | Q37191562 | ||
| Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections from children in Yucatan, Mexico. | Q37208613 | ||
| Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. | Q37319790 | ||
| Shigella in Brazilian children with acute diarrhoea: prevalence, antimicrobial resistance and virulence genes | Q37682165 | ||
| Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. | Q38000763 | ||
| Foodborne outbreaks in Canada linked to produce: 2001 through 2009. | Q38073965 | ||
| Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea | Q39453145 | ||
| Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells | Q39610195 | ||
| Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial | Q40501431 | ||
| Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children | Q40552513 | ||
| Treatment of shigellosis with cefixime: two days vs. five days | Q40619200 | ||
| Treatment of Shigellosis: IV. Cefixime Is Ineffective in Shigellosis in Adults | Q40679661 | ||
| The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. | Q40793797 | ||
| Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon. | Q43275646 | ||
| Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention | Q43517699 | ||
| Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? | Q44995461 | ||
| Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. | Q45138749 | ||
| Optimization of virulence functions through glucosylation of Shigella LPS. | Q45282739 | ||
| Outbreaks of Shigella sonnei infections in Denmark and Australia linked to consumption of imported raw baby corn | Q46169105 | ||
| Molecular epidemiology of multidrug-resistant Shigella dysenteriae type 1 causing dysentery outbreaks in Central African Republic, 2003-2004. | Q46317417 | ||
| Epidemic Shiga bacillus dysentery in Central Africa | Q46490035 | ||
| Burden and transmission of zoonotic foodborne disease in a rural community in Mexico | Q46959663 | ||
| Epidemiologilogical, Clinical and Microbiological Features of Shigellosis among Hospitalized Children in Northern Israel | Q47214975 | ||
| Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea | Q47361536 | ||
| Epidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969 | Q47770578 | ||
| Variation in the Shiga toxin region of 20th-century epidemic and endemic Shigella dysenteriae 1 strains | Q48185292 | ||
| Seizure and altered mental status in a 12-year-old child with Shigella sonnei gastroenteritis. | Q51816171 | ||
| Multidrug-resistant Shigella dysenteriae type 1 in south Asia. | Q53909767 | ||
| Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India. | Q54319602 | ||
| Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand. | Q54365148 | ||
| Correction for Paciello et al., Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation | Q57630118 | ||
| Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers | Q64134965 | ||
| Plasmid-mediated intracellular multiplication of Shigella flexneri | Q68217754 | ||
| Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells | Q79298186 | ||
| Diarrhea associated with Shigella in children and susceptibility to antimicrobials | Q82532748 | ||
| Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine | Q84592118 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 81-87 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Current tropical medicine reports | Q27725408 |
| P1476 | title | Shigella: A Highly Virulent and Elusive Pathogen | |
| P478 | volume | 1 |
| Q47691936 | Bacteriophage application for biocontrolling Shigella flexneri in contaminated foods |
| Q58277163 | Determination ofShigella flexneriby a Novel Fluorescent Aptasensor |
| Q90183370 | Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri |
| Q37196263 | Multidrug-Resistant Shigella Infections in Patients with Diarrhea, Cambodia, 2014-2015. |
| Q40092789 | Profiling of Virulence-associated Factors in Shigella Species Isolated from Acute Pediatric Diarrheal Samples in Tehran, Iran |
| Q41669177 | Shiga Toxin Therapeutics: Beyond Neutralization. |
| Q36026230 | Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance |
| Q26825840 | The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery |
Search more.